Horizon (HZNP) Provides Preliminary 2020 Financial Results
Horizon Therapeutics plc HZNP provided 2020 preliminary financial results, and updates on the supply of its biologic, Tepezza, approved for the treatment of Thyroid Eye Disease (TED),and the new studies on its biologic, Krystexxa, for more...
Ultragenyx (RARE) Presents Preliminary 2020 Revenues & Guidance
Ultragenyx Pharmaceutical Inc. RARE reported preliminary 2020 Crysvita revenues and provided 2021 revenue guidance for the same. Crysvita revenues in Ultragenyx territories for 2020 were in the range of $137-$139 million. Cash, cash equivalents and more...
New Strong Sell Stocks for January 12th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: Applied DNA Sciences, Inc. APDN is a developer and marketer of DNA-based technology solutions. The Zacks Consensus Estimate for its current more...
BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana
PURE EP(tm) system evaluation conducted under the leadership of Cardiologists Vinod Chauhan, M.D. and Deepak Gaba, M.D. Memorial Hospital is nationally recognized for its emphasis on innovation. Westport, CT, Jan. 12, 2021 (GLOBE NEWSWIRE) — more...
American Manganese’s Wenden Stockpile Testing Project is Underway and on Schedule
Publication in Journal of the Electrochemical Society Ranks in the Top 5% of all 16.5 Million Research Outputs Tracked by Altmetric SURREY, BC / ACCESSWIRE / January 12, 2021 / American Manganese Inc. (TSXV:AMY)(OTC PINK:AMYZF)(FRA:2AM)(“AMY” more...
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
—Capricor to leverage Lonza’s expertise in technology transfer and development of cellular therapies to take CAP-1002 through potential product launch and commercial supply— —The collaboration aims to expand Capricor’s manufacturing capacity for potential late-stage clinical more...
Evofem Biosciences Wins Business Intelligence Group’s BIG Innovation Award 2021
Evofem Biosciences Wins Business Intelligence Group’s BIG Innovation Award 2021 Evofem honored amongst best companies globally for outstanding innovation with first-in-class non-hormonal prescription contraceptive vaginal gel, Phexxi® PR Newswire SAN DIEGO , Jan. 12, 2021 more...
O2Micro to Announce Fourth Quarter 2020 Results
GEORGE TOWN, Grand Cayman, Jan. 12, 2021 (GLOBE NEWSWIRE) — O2Micro® International Limited, (NASDAQ:OIIM), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, will announce its financial results for more...
BIOLASE Announces Agreement With DSO Dental Care Alliance To Expand Laser Adoption In Dental Offices Across The United States
BIOLASE Announces Agreement With DSO Dental Care Alliance To Expand Laser Adoption In Dental Offices Across The United States PR Newswire FOOTHILL RANCH, Calif. , Jan. 12, 2021 /PRNewswire/ — BIOLASE , Inc. (NASDAQ: BIOL), more...
Day One of Bionano’s Next-Generation Cytogenomics Symposium: Customer Progress in Applications Development in Prenatal Testing, Validation Against Traditional Cytogenetics and Resolution for Undiagnosed Patients
Path to LDT for prenatal genetic test of positive NIPT cases presented 100% concordance with standard cytogenetic and molecular methods in genetic diseases reported Resolution of undiagnosed rare diseases using OGM in US, Europe and more...